Correlation Between Janux Therapeutics and Erytech Pharma
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Erytech Pharma SA, you can compare the effects of market volatilities on Janux Therapeutics and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Erytech Pharma.
Diversification Opportunities for Janux Therapeutics and Erytech Pharma
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Janux and Erytech is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Erytech Pharma go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Erytech Pharma
If you would invest 5,041 in Janux Therapeutics on August 28, 2024 and sell it today you would lose (159.00) from holding Janux Therapeutics or give up 3.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.79% |
| Values | Daily Returns |
Janux Therapeutics vs. Erytech Pharma SA
Performance |
| Timeline |
| Janux Therapeutics |
| Erytech Pharma SA |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Janux Therapeutics and Erytech Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Janux Therapeutics and Erytech Pharma
The main advantage of trading using opposite Janux Therapeutics and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.| Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Scpharmaceuticals | Janux Therapeutics vs. Milestone Pharmaceuticals | Janux Therapeutics vs. Seres Therapeutics |
| Erytech Pharma vs. Genfit | Erytech Pharma vs. Eliem Therapeutics | Erytech Pharma vs. HCW Biologics | Erytech Pharma vs. Aptorum Group Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |